 Gregory Austin
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Pump Inhibitors | 7 | 2018 | 98 | 3.170 |
Why?
| | Adenoma | 9 | 2022 | 191 | 3.030 |
Why?
| | Gastric Bypass | 6 | 2017 | 93 | 2.850 |
Why?
| | Colonoscopy | 10 | 2022 | 208 | 2.780 |
Why?
| | Colorectal Neoplasms | 10 | 2022 | 628 | 2.500 |
Why?
| | Obesity, Morbid | 6 | 2017 | 197 | 2.180 |
Why?
| | Energy Intake | 6 | 2015 | 447 | 1.650 |
Why?
| | Weight Loss | 5 | 2017 | 655 | 1.300 |
Why?
| | Intestines | 3 | 2017 | 332 | 1.290 |
Why?
| | Gastric Acid | 3 | 2015 | 15 | 1.120 |
Why?
| | Gastroesophageal Reflux | 3 | 2015 | 248 | 1.080 |
Why?
| | Laparoscopy | 5 | 2017 | 417 | 1.050 |
Why?
| | Postoperative Care | 2 | 2015 | 237 | 0.920 |
Why?
| | Colonic Polyps | 2 | 2021 | 70 | 0.900 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2017 | 514 | 0.890 |
Why?
| | Body Mass Index | 7 | 2018 | 2092 | 0.830 |
Why?
| | Medicaid | 2 | 2016 | 411 | 0.810 |
Why?
| | Diet | 5 | 2015 | 1153 | 0.770 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2021 | 56 | 0.770 |
Why?
| | Education | 1 | 2020 | 105 | 0.710 |
Why?
| | Microbiota | 4 | 2017 | 656 | 0.700 |
Why?
| | Conscious Sedation | 1 | 2020 | 79 | 0.690 |
Why?
| | Bariatric Surgery | 1 | 2021 | 166 | 0.670 |
Why?
| | Mentors | 1 | 2020 | 166 | 0.650 |
Why?
| | Research Personnel | 1 | 2020 | 158 | 0.650 |
Why?
| | Mentoring | 1 | 2020 | 101 | 0.640 |
Why?
| | Diet, Carbohydrate-Restricted | 2 | 2009 | 31 | 0.630 |
Why?
| | Obesity | 5 | 2015 | 2746 | 0.610 |
Why?
| | Triage | 1 | 2020 | 203 | 0.610 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 360 | 0.610 |
Why?
| | Middle Aged | 32 | 2020 | 27617 | 0.600 |
Why?
| | Nutrition Surveys | 5 | 2018 | 233 | 0.590 |
Why?
| | Gastrectomy | 1 | 2017 | 82 | 0.560 |
Why?
| | Weight Gain | 2 | 2015 | 493 | 0.530 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 1798 | 0.490 |
Why?
| | Antidepressive Agents | 1 | 2015 | 189 | 0.480 |
Why?
| | Preoperative Care | 1 | 2016 | 332 | 0.470 |
Why?
| | Female | 36 | 2020 | 61564 | 0.460 |
Why?
| | Male | 34 | 2020 | 57801 | 0.460 |
Why?
| | Midazolam | 1 | 2013 | 49 | 0.460 |
Why?
| | Insurance Coverage | 1 | 2015 | 208 | 0.460 |
Why?
| | Dietary Sucrose | 1 | 2013 | 55 | 0.450 |
Why?
| | Fentanyl | 1 | 2013 | 70 | 0.440 |
Why?
| | Adult | 26 | 2020 | 31512 | 0.440 |
Why?
| | Humans | 48 | 2022 | 118972 | 0.430 |
Why?
| | Insulin Resistance | 2 | 2018 | 1180 | 0.430 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2007 | 290 | 0.420 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 578 | 0.420 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2018 | 589 | 0.420 |
Why?
| | Motor Activity | 2 | 2015 | 660 | 0.400 |
Why?
| | Dietary Fats | 1 | 2013 | 322 | 0.390 |
Why?
| | Medicare | 1 | 2016 | 663 | 0.390 |
Why?
| | Length of Stay | 2 | 2015 | 1032 | 0.380 |
Why?
| | Education, Medical | 2 | 2013 | 239 | 0.380 |
Why?
| | Aged | 15 | 2020 | 19657 | 0.370 |
Why?
| | Patient Readmission | 1 | 2015 | 634 | 0.350 |
Why?
| | Predictive Value of Tests | 6 | 2020 | 1868 | 0.340 |
Why?
| | Intestinal Mucosa | 4 | 2018 | 531 | 0.340 |
Why?
| | Irritable Bowel Syndrome | 1 | 2009 | 29 | 0.340 |
Why?
| | Ethanol | 1 | 2013 | 575 | 0.340 |
Why?
| | Diarrhea | 1 | 2009 | 181 | 0.310 |
Why?
| | Inflammation | 1 | 2018 | 2566 | 0.310 |
Why?
| | Retrospective Studies | 12 | 2017 | 12978 | 0.310 |
Why?
| | Serologic Tests | 1 | 2007 | 52 | 0.300 |
Why?
| | Dysbiosis | 3 | 2017 | 147 | 0.300 |
Why?
| | Family | 1 | 2011 | 585 | 0.290 |
Why?
| | Health Services Research | 1 | 2010 | 385 | 0.290 |
Why?
| | Fellowships and Scholarships | 1 | 2010 | 250 | 0.290 |
Why?
| | Colon | 3 | 2018 | 238 | 0.280 |
Why?
| | Meat | 1 | 2007 | 89 | 0.280 |
Why?
| | Fruit | 1 | 2007 | 130 | 0.280 |
Why?
| | Alcohol Drinking | 2 | 2013 | 652 | 0.280 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1067 | 0.280 |
Why?
| | HIV Infections | 5 | 2018 | 2459 | 0.260 |
Why?
| | Exercise | 1 | 2015 | 1657 | 0.260 |
Why?
| | Young Adult | 9 | 2020 | 10793 | 0.250 |
Why?
| | Practice Patterns, Physicians' | 1 | 2012 | 1200 | 0.240 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2016 | 176 | 0.240 |
Why?
| | Mass Screening | 1 | 2011 | 1052 | 0.230 |
Why?
| | Time Factors | 6 | 2017 | 6412 | 0.230 |
Why?
| | Aging | 1 | 2013 | 1670 | 0.230 |
Why?
| | United States | 6 | 2018 | 12555 | 0.220 |
Why?
| | Risk Factors | 8 | 2020 | 9000 | 0.210 |
Why?
| | Cohort Studies | 3 | 2017 | 5116 | 0.200 |
Why?
| | Gastric Acidity Determination | 2 | 2014 | 7 | 0.200 |
Why?
| | Liver Transplantation | 2 | 2011 | 847 | 0.200 |
Why?
| | Cross-Sectional Studies | 5 | 2018 | 4552 | 0.200 |
Why?
| | HIV-1 | 3 | 2017 | 776 | 0.190 |
Why?
| | Age Factors | 2 | 2020 | 2995 | 0.190 |
Why?
| | Adenomatous Polyps | 1 | 2020 | 9 | 0.180 |
Why?
| | Treatment Outcome | 6 | 2017 | 9342 | 0.180 |
Why?
| | Biomarkers | 4 | 2018 | 3588 | 0.180 |
Why?
| | Blood Component Transfusion | 2 | 2011 | 84 | 0.180 |
Why?
| | Iron | 1 | 2021 | 248 | 0.180 |
Why?
| | Smoking | 1 | 2007 | 1487 | 0.180 |
Why?
| | Case-Control Studies | 5 | 2016 | 3171 | 0.170 |
Why?
| | Colorado | 4 | 2020 | 4196 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1440 | 0.160 |
Why?
| | Quality of Life | 1 | 2009 | 2366 | 0.160 |
Why?
| | Follow-Up Studies | 4 | 2014 | 4596 | 0.160 |
Why?
| | Sex Factors | 2 | 2013 | 1781 | 0.160 |
Why?
| | Interferon Type I | 1 | 2018 | 129 | 0.150 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 509 | 0.150 |
Why?
| | Narrow Band Imaging | 2 | 2016 | 14 | 0.150 |
Why?
| | Acute Lung Injury | 2 | 2011 | 310 | 0.150 |
Why?
| | Bacterial Translocation | 1 | 2017 | 36 | 0.150 |
Why?
| | Immunity, Mucosal | 1 | 2017 | 86 | 0.150 |
Why?
| | Biliary Tract Diseases | 1 | 2016 | 35 | 0.150 |
Why?
| | Solutions | 1 | 2017 | 156 | 0.150 |
Why?
| | Genitalia | 1 | 2016 | 27 | 0.140 |
Why?
| | Guideline Adherence | 1 | 2021 | 523 | 0.140 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 4708 | 0.140 |
Why?
| | Butyrates | 1 | 2017 | 54 | 0.140 |
Why?
| | Pancreatic Diseases | 1 | 2016 | 63 | 0.140 |
Why?
| | Aged, 80 and over | 3 | 2018 | 6561 | 0.140 |
Why?
| | Polyethylene | 1 | 2016 | 10 | 0.140 |
Why?
| | Immunologic Factors | 1 | 2018 | 225 | 0.140 |
Why?
| | Esophagogastric Junction | 1 | 2016 | 41 | 0.140 |
Why?
| | Hernia, Hiatal | 1 | 2016 | 34 | 0.140 |
Why?
| | Esophageal Motility Disorders | 1 | 2016 | 24 | 0.140 |
Why?
| | Program Evaluation | 1 | 2020 | 845 | 0.130 |
Why?
| | Emtricitabine | 1 | 2016 | 146 | 0.130 |
Why?
| | Pancreatitis, Chronic | 1 | 2016 | 39 | 0.130 |
Why?
| | Endosonography | 2 | 2016 | 142 | 0.130 |
Why?
| | Dementia | 1 | 2018 | 208 | 0.130 |
Why?
| | Rectum | 1 | 2016 | 157 | 0.130 |
Why?
| | Pancreatic Ducts | 1 | 2016 | 66 | 0.130 |
Why?
| | Tenofovir | 1 | 2016 | 200 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1795 | 0.130 |
Why?
| | Verrucomicrobia | 1 | 2014 | 6 | 0.130 |
Why?
| | Bacteroidetes | 1 | 2014 | 22 | 0.130 |
Why?
| | Proteobacteria | 1 | 2014 | 17 | 0.130 |
Why?
| | Cholangitis, Sclerosing | 2 | 2016 | 75 | 0.120 |
Why?
| | Mucous Membrane | 1 | 2015 | 113 | 0.120 |
Why?
| | Esophagus | 1 | 2016 | 237 | 0.120 |
Why?
| | Diet Records | 1 | 2013 | 81 | 0.120 |
Why?
| | Anesthetics, Intravenous | 1 | 2013 | 34 | 0.110 |
Why?
| | Veterans | 1 | 2004 | 1208 | 0.110 |
Why?
| | Polyps | 1 | 2013 | 13 | 0.110 |
Why?
| | Multivariate Analysis | 2 | 2007 | 1474 | 0.110 |
Why?
| | Immunity | 1 | 2014 | 129 | 0.110 |
Why?
| | Endotoxemia | 1 | 2014 | 93 | 0.110 |
Why?
| | Prevalence | 2 | 2011 | 2326 | 0.110 |
Why?
| | Dietary Carbohydrates | 1 | 2013 | 153 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2016 | 1223 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2016 | 482 | 0.110 |
Why?
| | Bile Duct Neoplasms | 1 | 2012 | 55 | 0.110 |
Why?
| | Stents | 1 | 2016 | 457 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 2 | 2017 | 548 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1185 | 0.100 |
Why?
| | C-Reactive Protein | 1 | 2013 | 360 | 0.100 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 13 | 0.100 |
Why?
| | Cluster Analysis | 2 | 2017 | 481 | 0.100 |
Why?
| | Prospective Studies | 4 | 2016 | 6471 | 0.100 |
Why?
| | Kidney | 1 | 2018 | 1353 | 0.100 |
Why?
| | Gastroenterology | 1 | 2013 | 158 | 0.100 |
Why?
| | Adolescent | 4 | 2018 | 18480 | 0.090 |
Why?
| | Bacteria | 1 | 2017 | 757 | 0.090 |
Why?
| | Fatty Acids | 1 | 2013 | 407 | 0.090 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 664 | 0.090 |
Why?
| | Feeding Behavior | 1 | 2015 | 601 | 0.090 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 702 | 0.090 |
Why?
| | Pancreatitis | 1 | 2010 | 108 | 0.090 |
Why?
| | Colitis, Ulcerative | 1 | 2011 | 105 | 0.090 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 554 | 0.090 |
Why?
| | Pancreatic Neoplasms | 2 | 2016 | 734 | 0.090 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2010 | 109 | 0.090 |
Why?
| | Reference Values | 1 | 2011 | 774 | 0.090 |
Why?
| | Health Care Costs | 1 | 2012 | 394 | 0.090 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 984 | 0.080 |
Why?
| | Erythrocyte Transfusion | 1 | 2011 | 210 | 0.080 |
Why?
| | Patient Discharge | 1 | 2015 | 796 | 0.080 |
Why?
| | Cross Infection | 1 | 2011 | 205 | 0.080 |
Why?
| | Regression Analysis | 1 | 2011 | 983 | 0.080 |
Why?
| | Crohn Disease | 1 | 2011 | 197 | 0.080 |
Why?
| | Linoleic Acids, Conjugated | 1 | 2007 | 5 | 0.080 |
Why?
| | North Carolina | 1 | 2007 | 109 | 0.070 |
Why?
| | Antibodies, Fungal | 1 | 2006 | 9 | 0.070 |
Why?
| | Porins | 1 | 2006 | 12 | 0.070 |
Why?
| | Prognosis | 3 | 2011 | 3443 | 0.070 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2006 | 35 | 0.070 |
Why?
| | Intensive Care Units | 1 | 2010 | 635 | 0.070 |
Why?
| | Antibodies, Bacterial | 1 | 2006 | 126 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2011 | 745 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2006 | 536 | 0.060 |
Why?
| | Life Style | 1 | 2007 | 430 | 0.060 |
Why?
| | Immunoglobulin A | 1 | 2006 | 174 | 0.060 |
Why?
| | Liver Failure | 1 | 2004 | 85 | 0.060 |
Why?
| | Body Composition | 1 | 2007 | 653 | 0.060 |
Why?
| | Viral Load | 2 | 2015 | 419 | 0.050 |
Why?
| | External Fixators | 2 | 1999 | 15 | 0.050 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 348 | 0.050 |
Why?
| | Biopsy | 2 | 2018 | 1079 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2006 | 788 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1384 | 0.050 |
Why?
| | Hepatitis C | 1 | 2004 | 217 | 0.050 |
Why?
| | Incidence | 1 | 2007 | 2424 | 0.050 |
Why?
| | Range of Motion, Articular | 2 | 1999 | 369 | 0.040 |
Why?
| | Survival Rate | 1 | 2004 | 1720 | 0.040 |
Why?
| | Colles' Fracture | 1 | 1999 | 2 | 0.040 |
Why?
| | Fracture Healing | 1 | 1999 | 74 | 0.040 |
Why?
| | Wrist Joint | 1 | 1999 | 53 | 0.040 |
Why?
| | Radius Fractures | 1 | 1999 | 50 | 0.040 |
Why?
| | Fracture Fixation | 1 | 1999 | 81 | 0.040 |
Why?
| | Health Literacy | 1 | 2020 | 169 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 79 | 0.040 |
Why?
| | Choledochal Cyst | 1 | 2016 | 20 | 0.040 |
Why?
| | Biliary Tract Neoplasms | 1 | 2016 | 20 | 0.040 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2016 | 28 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3057 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 203 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 91 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 156 | 0.030 |
Why?
| | Manometry | 1 | 2016 | 89 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 314 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 9 | 0.030 |
Why?
| | Endoscopy, Digestive System | 1 | 2016 | 111 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 12 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 829 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2016 | 269 | 0.030 |
Why?
| | Colitis | 1 | 2017 | 219 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 60 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 699 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 154 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 80 | 0.030 |
Why?
| | Feces | 1 | 2017 | 396 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1085 | 0.030 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2016 | 210 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 755 | 0.030 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 267 | 0.030 |
Why?
| | Glycoproteins | 1 | 2015 | 319 | 0.030 |
Why?
| | Cell Lineage | 1 | 2015 | 318 | 0.030 |
Why?
| | Histocytochemistry | 1 | 2013 | 82 | 0.030 |
Why?
| | Phylogeny | 1 | 2017 | 816 | 0.030 |
Why?
| | Pilot Projects | 1 | 2017 | 1419 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 446 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 460 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2015 | 442 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 3003 | 0.030 |
Why?
| | Interferon-gamma | 1 | 2015 | 736 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1597 | 0.030 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 396 | 0.030 |
Why?
| | Granulocytes | 1 | 2011 | 79 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2275 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 963 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 143 | 0.020 |
Why?
| | Biodiversity | 1 | 2014 | 378 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 525 | 0.020 |
Why?
| | ROC Curve | 1 | 2011 | 473 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 189 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 627 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 996 | 0.020 |
Why?
| | Cadaver | 2 | 1999 | 327 | 0.020 |
Why?
| | Rest | 1 | 2007 | 104 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1633 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2011 | 814 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 1901 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2445 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2007 | 187 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 736 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2011 | 2657 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2674 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2007 | 1687 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 934 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 4709 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2007 | 767 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 182 | 0.010 |
Why?
| | Bone Wires | 1 | 1999 | 21 | 0.010 |
Why?
| | Weight-Bearing | 1 | 1999 | 172 | 0.010 |
Why?
| | Osteotomy | 1 | 1999 | 158 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1999 | 683 | 0.010 |
Why?
| | Models, Biological | 1 | 1999 | 1715 | 0.010 |
Why?
|
|
Austin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|